Predictive Value of Gastrointestinal Blood Flow for Enteral Nutrition Intolerance in Critically Ill Patients

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial is studying gastrointestinal blood flow as a way to predict whether critically ill patients will tolerate tube feeding — if I or my family member ends up in the ICU needing enteral nutrition, could this kind of monitoring change how the care team decides to manage feeding?
2. 2Since this study is categorized as 'Phase NA' and focuses on prediction and machine learning rather than a new treatment, does participating mean any change to the actual care I receive, or is it mainly observation and data collection?
3. 3The trial is actively recruiting — what would actually be involved day-to-day if we agreed to participate, and would any extra tests or monitoring add burden during an already stressful critical illness?
4. 4If enteral nutrition intolerance is a real risk in my situation, what are the current standard methods doctors use to detect or prevent it, and how does what this trial is studying compare to that existing approach?
5. 5Given that this study is building a prediction model rather than testing a new therapy, what benefit — if any — might there be to participating now, versus simply benefiting later if the model is eventually adopted into standard ICU care?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.